Industry Showcase TechTonic Shift: Prescription Digital Therapeutics and the Future of Psychiatric Pharmacy Supported by Boehringer Ingelheim

Discover the transformative potential of prescription digital therapeutics (PDTs), including a deep dive into the evidence supporting these technologies as effective treatments for patients with serious mental illnesses. In this industry showcase, distinguished faculty with expertise in the development and implementation of digital technologies into healthcare systems will discuss the evaluation of digital therapies in clinical trials and real-world studies in mental health conditions and how they may be implemented into practice.

Course Requirements

To receive ACPE credit for this session, you must:

  • Register for this course.
  • Review the full content of the activity and reflect upon its teachings.
  • Complete the evaluation at the end of the activity.
  • Provide the necessary details in your profile to ensure correct reporting by AAPP to CPE Monitor.

Faculty Information

Kari Franson, PharmD, PhD, BCPP
Lisa Marsch, PhD
Nathaniel Rickles, PharmD, PhD, BCPP
View biographical information

Kari Franson, PharmD, PhD, BCPP
Senior Associate Dean for Academic and Student Affairs & Professor of Clinical Pharmacy
Titus Family Department of Clinical Pharmacy
USC Mann School of Pharmacy & Pharmaceutical Sciences

Lisa Marsch, PhD
Director for the Dartmouth Center for Technology and Behavioral Health (CTBH)
Andrew G. Wallace Professor within the Departments of Psychiatry and Biomedical Data Science
Geisel School of Medicine at Dartmouth College

Nathaniel Rickles, PharmD, PhD, BCPP
Associate Dean of Admissions and Student Affairs
Professor of Pharmacy Practice
Institute for Collaboration on Health, Intervention, and Policy (InCHIP) at the University of Connecticut

Learning Objectives

  1. Review the challenges and unmet needs experienced by psychiatric pharmacists in the delivery of mental health care including potential solutions.
  2. Educate on digital therapeutic research from early phase investigational studies, registrational trials, and real-world evidence in mental illness.
  3. Explore the role of psychiatric pharmacists in the implementation and utilization of digital therapeutics into treatment of mental health disorders.

Continuing Education Credit and Disclosures

View AAPP's Privacy Policy

AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.

Questions? Contact AAPP.